![\"\"](\"https:\/\/i12.haber7.net\/\/haber\/haber7\/photos\/2021\/27\/IexzZ_1625559249_383.jpg\")
<\/p>\n\n\n\nSa\u011fl\u0131k Bakanl\u0131\u011f\u0131 Bilim Kurulu, hastal\u0131\u011f\u0131 ge\u00e7irenlerde BioNTech tercih edenler i\u00e7in tek doz uygulanmas\u0131 karar\u0131 ald\u0131.<\/p>\n\n\n\n
Bilim Kurulu’nun bu karar\u0131 tart\u0131\u015fmalara neden oldu. Bilim Kurulu \u00dcyesi ve Ankara \u015eehir Hastanesi Yo\u011fun Bak\u0131m Uzman\u0131 Prof. Dr. Sema Turan, d\u00fcnyada hastal\u0131\u011f\u0131 ge\u00e7irmi\u015f ki\u015filerde 6 ay sonra antikor seviyelerindeki d\u00fc\u015f\u00fc\u015fe ba\u011fl\u0131 a\u015f\u0131lama program\u0131na al\u0131nma gereklili\u011finin tart\u0131\u015f\u0131lan bir konu oldu\u011funu s\u00f6yledi.<\/p>\n\n\n\n
<\/p>\n\n\n\n
Prof. Dr. Turan, “Bu nedenle biz de bu grup bireylerde 6’nc\u0131 ay\u0131n\u0131 ge\u00e7irdikten sonra hastal\u0131\u011fa kar\u015f\u0131 koruyucu olsun diye tek doz a\u015f\u0131 uygulamas\u0131n\u0131 yapma karar\u0131 ald\u0131k. Bu karara istinaden de takip bu bireylerde devam ediyor. E\u011fer bu uygulama antikor filtrelerinde ba\u015far\u0131 olur ise tek dozda kalmak bu grup hastalarda m\u00fcmk\u00fcn olabilir. Sonu\u00e7ta hastal\u0131\u011f\u0131 ge\u00e7irenlerin vir\u00fcse kar\u015f\u0131 bir haf\u0131zalar\u0131 var. Yani v\u00fccudun ge\u00e7irdi\u011fi hastal\u0131klara ba\u011fl\u0131 bir v\u00fccutta bir ba\u011f\u0131\u015f\u0131kl\u0131k oldu\u011fu i\u00e7in bu bireylerde tek doz a\u015f\u0131n\u0131n yeterli olaca\u011f\u0131 ile ilgili \u015fu an elimizde bulunan literat\u00fcrdeki bilgiler \u0131\u015f\u0131\u011f\u0131nda al\u0131nm\u0131\u015f bir karar bu” <\/strong>diye konu\u015ftu. ‘A\u015eILAMA \u0130NAKT\u0130F BA\u015eLADI\u011eI \u0130\u00c7\u0130N HATIRLATMA DOZU’<\/strong> KAYNAK: DHA<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":" Kovid-19 a\u015f\u0131lama program\u0131nda ikinci doz i\u00e7in randevu alan koronavir\u00fcs ge\u00e7irmi\u015f vatanda\u015flar\u0131n randevular\u0131 iptal edildi. Bilim…<\/p>\n","protected":false},"author":2,"featured_media":1614,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[42],"tags":[],"class_list":["post-1613","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-turkiye"],"_links":{"self":[{"href":"https:\/\/qafqaztimes.com\/tr\/wp-json\/wp\/v2\/posts\/1613"}],"collection":[{"href":"https:\/\/qafqaztimes.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/qafqaztimes.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/qafqaztimes.com\/tr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/qafqaztimes.com\/tr\/wp-json\/wp\/v2\/comments?post=1613"}],"version-history":[{"count":2,"href":"https:\/\/qafqaztimes.com\/tr\/wp-json\/wp\/v2\/posts\/1613\/revisions"}],"predecessor-version":[{"id":1616,"href":"https:\/\/qafqaztimes.com\/tr\/wp-json\/wp\/v2\/posts\/1613\/revisions\/1616"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/qafqaztimes.com\/tr\/wp-json\/wp\/v2\/media\/1614"}],"wp:attachment":[{"href":"https:\/\/qafqaztimes.com\/tr\/wp-json\/wp\/v2\/media?parent=1613"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/qafqaztimes.com\/tr\/wp-json\/wp\/v2\/categories?post=1613"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/qafqaztimes.com\/tr\/wp-json\/wp\/v2\/tags?post=1613"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
<\/p>\n\n\n\n
Prof. Dr. Turan, 6 ay sonra hat\u0131rlatma dozu a\u015f\u0131s\u0131 uygulamas\u0131n\u0131n da yine d\u00fcnyadaki veriler \u0131\u015f\u0131\u011f\u0131nda, literat\u00fcr bilgisi \u0131\u015f\u0131\u011f\u0131nda al\u0131nan bir karar oldu\u011funu kaydetti. Prof. Dr. Turan, “Hastal\u0131\u011f\u0131 ge\u00e7irenlerde 6’nc\u0131 ay\u0131ndan sonra hatta vir\u00fcsteki varyasyonlar nedeniyle bunu 3 aya \u00e7eken \u00fclkeler de bulunmakta; o y\u00fczden de bir hat\u0131rlatma dozu a\u015f\u0131s\u0131 yap\u0131labilir. Hastal\u0131\u011f\u0131 ge\u00e7irenler i\u00e7in bu a\u015f\u0131n\u0131n da \u00fclkemizde BioNTech a\u015f\u0131s\u0131 olarak se\u00e7ene\u011fi sunulmu\u015ftur. 2 doz inaktif a\u015f\u0131 ile a\u015f\u0131lanan bireylerde ise 3 ila 6 ay sonra n\u00f6tralizan antikor d\u00fczeylerindeki d\u00fc\u015f\u00fc\u015fe ba\u011fl\u0131 olarak hat\u0131rlatma dozu yap\u0131lmas\u0131 gereklili\u011fi g\u00f6r\u00fclm\u00fc\u015ft\u00fcr. Bu hat\u0131rlatma dozu 2 doz inaktif a\u015f\u0131 olanlarda tercihe g\u00f6re mRNA ya da inaktif a\u015f\u0131 olabilir. Avrupa \u00fclkelerinde \u00e7o\u011funlukta mRNA teknolojisine g\u00f6re haz\u0131rlanm\u0131\u015f a\u015f\u0131lar\u0131n kullan\u0131lmas\u0131 nedeniyle onlarda 3\u2019\u00fcnc\u00fc doz konusu bizdekinden farkl\u0131 olarak ele al\u0131nmaktad\u0131r. Bizim \u00fclkemizde inaktif a\u015f\u0131 ile a\u015f\u0131lama s\u00fcrecinin ba\u015flamas\u0131 sebebiyle b\u00f6yle bir karar al\u0131nm\u0131\u015ft\u0131r” dedi.
‘YETERL\u0130 A\u015eI BULUNMAKTADIR<\/strong>
Prof. Dr. Turan, a\u015f\u0131lama s\u00fcrecinin ba\u015far\u0131yla devam etti\u011fini vurgulayarak, “Halk\u0131n a\u015f\u0131ya uyumu da \u00e7ok ba\u015far\u0131l\u0131. Halk\u0131m\u0131z a\u015f\u0131 olmak i\u00e7in \u00e7ok istekli. A\u015f\u0131lama d\u00fczg\u00fcn ve uyumlu bir \u015fekilde gidiyor. D\u00fcnyada pek \u00e7ok \u00fclkeye \u00f6rnek olacak \u015fekilde a\u015f\u0131lama s\u00fcreci h\u0131zland\u0131 ve \u015fu anda halen h\u0131zl\u0131 bir \u015fekilde gitmektedir. Sonu\u00e7ta U\u011fur \u015eahin hocam\u0131z\u0131n teyit etti\u011fi \u00fczere a\u015f\u0131lar s\u00f6ylendi\u011fi miktarlarda gelmektedir. Hi\u00e7bir sorun yok. T\u00fcrkiye\u2019nin elinde yeterli a\u015f\u0131 bulunmaktad\u0131r. Zaten o kadar h\u0131zl\u0131 giden bir a\u015f\u0131lama s\u00fcrecinde aksini iddia etmekte bir o kadar anlams\u0131z” diye ifade etti. <\/p>\n\n\n\n